These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21543640)

  • 1. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
    Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
    J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
    Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
    Furuhashi M; Tuncman G; Görgün CZ; Makowski L; Atsumi G; Vaillancourt E; Kono K; Babaev VR; Fazio S; Linton MF; Sulsky R; Robl JA; Parker RA; Hotamisligil GS
    Nature; 2007 Jun; 447(7147):959-65. PubMed ID: 17554340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
    Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
    Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
    Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
    Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
    Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
    Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
    Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of fatty acid-binding protein 4 during mouse decidualization.
    Tian Z; Zhao ZA; Liang XH; Zhang XH; Sha AG; Zhang ZR; Yu YS; Yang ZM
    Fertil Steril; 2011 Jun; 95(8):2749-52.e1-5. PubMed ID: 21704217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.
    Mosińska P; Jacenik D; Sałaga M; Wasilewski A; Cygankiewicz A; Sibaev A; Mokrowiecka A; Małecka-Panas E; Pintelon I; Storr M; Timmermans JP; Krajewska WM; Fichna J
    Neurogastroenterol Motil; 2018 May; 30(5):e13272. PubMed ID: 29266569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.
    Cai H; Yan G; Zhang X; Gorbenko O; Wang H; Zhu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3675-9. PubMed ID: 20471252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4.
    Song J; Ren P; Zhang L; Wang XL; Chen L; Shen YH
    Biochem Biophys Res Commun; 2010 Feb; 393(1):89-94. PubMed ID: 20102700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts.
    Scifres CM; Chen B; Nelson DM; Sadovsky Y
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1083-91. PubMed ID: 21525163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
    Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
    Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes.
    Woo HM; Kang JH; Kawada T; Yoo H; Sung MK; Yu R
    Life Sci; 2007 Feb; 80(10):926-31. PubMed ID: 17196622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity.
    Kurokawa J; Arai S; Nakashima K; Nagano H; Nishijima A; Miyata K; Ose R; Mori M; Kubota N; Kadowaki T; Oike Y; Koga H; Febbraio M; Iwanaga T; Miyazaki T
    Cell Metab; 2010 Jun; 11(6):479-92. PubMed ID: 20519120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular growth and tube formation of HTR8/SVneo trophoblast: effects of exogenously added fatty acid-binding protein-4 and its inhibitor.
    Basak S; Sarkar A; Mathapati S; Duttaroy AK
    Mol Cell Biochem; 2018 Jan; 437(1-2):55-64. PubMed ID: 28620819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
    Zhang M; Zhu W; Li Y
    Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.